The WINGS Act (HR 4805) mandates VA study of long-term physiologic and psychological effects of military aviation exposures, including jet fuel and related substances, to better inform policy and ...

A single-center observational cohort (n=116; 81% RRMS) receiving ocrelizumab from 2018–2023 enabled longitudinal tracking of IgG, IgA, and IgM across treatment cycles. Serial dosing produced gradual ...

Legislation delays mandatory digital-only quality reporting for Shared Savings Program ACOs, addressing gaps in EHR/IT infrastructure that disproportionately affect smaller, rural, and independent ...

Increasing frontline covalent BTK inhibitor use and emerging BTKi+BCL2i+anti-CD20 triplets constrain the R/R BTK-naïve ...

AML management now hinges on molecularly defined subtypes, supported by numerous targeted approvals; expanding trial access ...

As discussed at a recent IVBM event, Robert Kratzke, MD, outlines essential biomarkers, NGS panel selection, and next steps ...

In this episode, 'Screening, Risk Stratification, and the Multidisciplinary Care Model for MASH,' the hepatologist Nadege Gunn, MD explores the following questions: 1. How would you characterize the ...

Indications now include pediatric plaque psoriasis and active PsA starting at age 6, positioning risankizumab as the first US-approved IL-23(p19) inhibitor for <40 kg pediatric patients. Weight-tiered ...

CDC ended the federal response June 24, 2026, after risk diminished, releasing >100 deployed staff from the peak incident ...

Life sciences executives are entering the second half of 2026 with a split view of their industry: deep unease about the ...

Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...

COA’s AI Playbook provides a structured, practice-oriented framework to prioritize AI use cases, align stakeholders, and ...